Your browser doesn't support javascript.
loading
Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients.
Gruber, Cesare Ernesto Maria; Tucci, Fabio Giovanni; Rueca, Martina; Mazzotta, Valentina; Gramigna, Giulia; Vergori, Alessandra; Fabeni, Lavinia; Berno, Giulia; Giombini, Emanuela; Butera, Ornella; Focosi, Daniele; Prandi, Ingrid Guarnetti; Chillemi, Giovanni; Nicastri, Emanuele; Vaia, Francesco; Girardi, Enrico; Antinori, Andrea; Maggi, Fabrizio.
Afiliación
  • Gruber CEM; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Tucci FG; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Rueca M; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Mazzotta V; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Gramigna G; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Vergori A; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Fabeni L; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Berno G; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Giombini E; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Butera O; Laboratory of Microbiology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, 56124 Pisa, Italy.
  • Prandi IG; Department for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), University of Tuscia, Via S. Camillo de Lellis s.n.c, 01100 Viterbo, Italy.
  • Chillemi G; Department for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), University of Tuscia, Via S. Camillo de Lellis s.n.c, 01100 Viterbo, Italy.
  • Nicastri E; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Vaia F; General Direction, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Girardi E; Scientific Direction, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Antinori A; Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Maggi F; Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
Biomolecules ; 13(10)2023 10 18.
Article en En | MEDLINE | ID: mdl-37892220
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pacientes Ambulatorios / Glicoproteína de la Espiga del Coronavirus Límite: Humans Idioma: En Revista: Biomolecules Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pacientes Ambulatorios / Glicoproteína de la Espiga del Coronavirus Límite: Humans Idioma: En Revista: Biomolecules Año: 2023 Tipo del documento: Article País de afiliación: Italia